Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
Kosaku Nitta,Shunsuke Goto,Ikuto Masakane,Norio Hanafusa,Masatomo Taniguchi,Takeshi Hasegawa,Shigeru Nakai,Atsushi Wada,Takayuki Hamano,Junichi Hoshino,Nobuhiko Joki,Masanori Abe,Keiichi Yamamoto,Hidetomo Nakamoto,Kazuyuki Maeno,Tetsuya Kawata,Chikara Oyama,Koji Seino,Toshinobu Sato,Shigeru Sato,Minoru Ito,Junichiro Kazama,Atsushi Ueda,Osamu Saito,Tetsuo Ando,Tomonari Ogawa,Hiroo Kumagai,Hiroyuki Terawaki,Ryoichi Ando,Masaki Abe,Tetsuya Kashiwagi,Chieko Hamada,Yugo Shibagaki,Nobuhito Hirawa,Hisaki Shimada,Yoichi Ishida,Hitoshi Yokoyama,Ryoichi Miyazaki,Mizuya Fukasawa,Yuji Kamijyo,Teppei Matsuoka,Akihiko Kato,Noriko Mori,Yasuhiko Ito,Hirotake Kasuga,Sukenari Koyabu,Tetsuro Arimura,Tetsuya Hashimoto,Masaaki Inaba,Terumasa Hayashi,Tomoyuki Yamakawa,Shinichi Nishi,Akira Fujimori,Tatsuo Yoneda,Shigeo Negi,Akihisa Nakaoka,Takafumi Ito,Hitoshi Sugiyama,Takao Masaki,Yutaka Nitta,Kazuyoshi Okada,Masahito Yamanaka,Masaharu Kan,Kazumichi Ota,Masahito Tamura,Koji Mitsuiki,Yuji Ikeda,Masaharu Nishikido,Akira Miyata,Tadashi Tomo,Shoichi Fujimoto,Tsuyoshi Nosaki,Yoshinori Oshiro,
DOI: https://doi.org/10.1186/s41100-020-00286-9
2020-09-04
Renal Replacement Therapy
Abstract:Abstract The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 facilities (98.7%) responded to the facility questionnaire, and 4222 (94.7%) responded to the patient questionnaire. The number of chronic dialysis patients in Japan continues to increase every year; as of the end of 2018, it had reached 339,841 patients, representing 2688 patients per million population. Among the prevalent dialysis patients, the mean age was 68.75 years, and diabetic nephropathy was the most common primary disease among the prevalent dialysis patients (39.0%), followed by chronic glomerulonephritis (26.8%) and nephrosclerosis (10.8%). The number of incident dialysis patients was 40,468, and a reduction by 491 from 2017. The mean age of the incident dialysis patients was 69.99 years old. Diabetic nephropathy was also the most common primary disease (42.3%), representing a 0.2 percent point reduction from 2017. The distribution of diabetic nephropathy appears to have reached a plateau. The number of deceased patients during 2018 was 33,863, and the crude annual death rate was 10.0%. Heart failure was the most common cause of death (23.5%), followed by infection (21.3%) and malignant tumor (8.4%); these causes were similar to those for 2017. The number of patients receiving hemodiafiltration has been increasing since 2012, reaching 125,793 or 37.0% of all dialysis patients at the end of 2018. The number of patients receiving peritoneal dialysis has been gradually increasing since 2017, reaching 9445, and 19.7% of these patients were treated using a combination of peritoneal dialysis and hemodialysis or hemodiafiltration. The proportion of patients receiving combination therapy has remained at around 20% of all peritoneal dialysis patients. The number of patients undergoing home hemodialysis was 720, representing an increase of 36 patients from 2017. The 2018 JRDR survey included several topics such as the present status of the patient kinetics of chronic dialysis patients at the end of 2018, water treatment and hemodiafiltration, peritoneal dialysis, treatments for diabetes, mental and physical conditions, and the present status of viral hepatitis. In this paper, we describe the patient and facility kinetics. Trial registration The JRDR was approved by the ethics committee of the JSDT (approval number 1-3) and was registered in the “University hospital Medical Information Network (UMIN) Clinical Trials Registry” under the clinical trial ID of UMIN000018641 on August 8, 2015: (Accessed June 2, 2020)